INSTITUT DE CANCEROLOGIE DE L'OUEST

Organization

Angers, FR

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Use of antibody against O-acetylated GD2 ganglioside to improve the...
- Patent number 11,697,689
- Issue date Jul 11, 2023
- OGD2 PHARMA
- Stéphane Birkle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for in vitro diagnosing and prognosing of triple negative br...
- Patent number 10,859,577
- Issue date Dec 8, 2020
- INSTITUT DE CANCEROLOGIE DE L'OUEST
- Catherine Guette
- G01 - MEASURING TESTING
Information Patent Grant
Olfactomedin-4, neudesin and desmoplakin as biomarkers of breast ca...
- Patent number 10,436,787
- Issue date Oct 8, 2019
- INSTITUT DE CANCEROLOGIE DE L'OUEST
- Catherine Guette
- G01 - MEASURING TESTING
Information Patent Grant
Use of the olfactomedin-4 protein (OLFM4) in colorectal cancer diag...
- Patent number 9,523,691
- Issue date Dec 20, 2016
- INSTITUT DE CANCEROLOGIE DE L'OUEST
- Catherine Guette
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Individual 5-fluorouracile dose optimization in folfiri treatment
- Patent number 9,463,193
- Issue date Oct 11, 2016
- INSTITUT DE CANCEROLOGIE DE L'OUEST
- Erick Gamelin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Low-Molecular-Weight HE800 Exopolysaccharide Derivatives with Anti-...
- Publication number 20240424015
- Publication date Dec 26, 2024
- INSTITUT FRANCAIS DE RECHERCHE POUR L'EXPLOITATION DE LA MER (IFREMER)
- Sylvia Colliec-Jouault
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF ANTIBODY AGAINST O-ACETYLATED GD2 GANGLIOSIDE TO IMPROVE THE...
- Publication number 20230416398
- Publication date Dec 28, 2023
- OGD2 PHARMA
- Stéphane BIRKLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD TO TREAT AND STRATIFICATE A PATIENT SUFFERING FROM A CANCER
- Publication number 20230357860
- Publication date Nov 9, 2023
- Inserm (institut National de la Sante et de la Recherche Medicale)
- Pierre-François CANTRON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD FOR TREATING AND PROGNOSING CANCER LIKE GLIOBLASTOMA
- Publication number 20230250426
- Publication date Aug 10, 2023
- Inserm (institut National de la Sante et de la Recherche Medicale)
- Pierre-François CARTRON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF ANTIBODY AGAINST O-ACETYLATED GD2 GANGLIOSIDE TO IMPROVE THE...
- Publication number 20190375853
- Publication date Dec 12, 2019
- OGD2 PHARMA
- Stéphane BIRKLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Olfactomedin-4, Neudesin and Desmoplakin as Biomarkers of Breast Ca...
- Publication number 20160291022
- Publication date Oct 6, 2016
- INSTITUT DE CANCEROLOGIE DE L'OUEST
- Catherine Guette
- G01 - MEASURING TESTING
Information Patent Application
Method for In Vitro Diagnosing and Prognosing of Triple Negative Br...
- Publication number 20160291021
- Publication date Oct 6, 2016
- INSTITUT DE CANCEROLOGIE DE L'OUEST
- Catherine Guette
- G01 - MEASURING TESTING
Information Patent Application
USE OF OLFACTOMEDIN-4 PROTEIN (OLFM4) IN COLORECTAL CANCER DIAGNOSIS
- Publication number 20130336969
- Publication date Dec 19, 2013
- INSTITUT DE CANCEROLOGIE DE L'OUEST
- Catherine Guette
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

INSTITUT DE CANCEROLOGIE DE L'OUEST

Organization

Patents Grantslast 30 patents

Use of antibody against O-acetylated GD2 ganglioside to improve the...

Method for in vitro diagnosing and prognosing of triple negative br...

Olfactomedin-4, neudesin and desmoplakin as biomarkers of breast ca...

Use of the olfactomedin-4 protein (OLFM4) in colorectal cancer diag...

Individual 5-fluorouracile dose optimization in folfiri treatment

Patents Applicationslast 30 patents

Low-Molecular-Weight HE800 Exopolysaccharide Derivatives with Anti-...

USE OF ANTIBODY AGAINST O-ACETYLATED GD2 GANGLIOSIDE TO IMPROVE THE...

METHOD TO TREAT AND STRATIFICATE A PATIENT SUFFERING FROM A CANCER

METHOD FOR TREATING AND PROGNOSING CANCER LIKE GLIOBLASTOMA

USE OF ANTIBODY AGAINST O-ACETYLATED GD2 GANGLIOSIDE TO IMPROVE THE...

Olfactomedin-4, Neudesin and Desmoplakin as Biomarkers of Breast Ca...

Method for In Vitro Diagnosing and Prognosing of Triple Negative Br...

USE OF OLFACTOMEDIN-4 PROTEIN (OLFM4) IN COLORECTAL CANCER DIAGNOSIS

Trademarklast 30 trademarks